首页> 外文学位 >Joint Genetic and MicroRNA Study of the Human Thrombocytosis under a System Biology Scheme.
【24h】

Joint Genetic and MicroRNA Study of the Human Thrombocytosis under a System Biology Scheme.

机译:系统生物学方案下人类血小板增多症的联合遗传和MicroRNA研究。

获取原文
获取原文并翻译 | 示例

摘要

The disease of human thrombocytosis is a type of myeloproliferative disorder (MPD) characterized by a complex alteration of genetic and epigenetic factors. Consequently, the pathological cellular environment is permeated by transcriptomic deregulation, interferomic aberrations, protein level irregularity and disrupted cellular pathways. In this dissertation, we present a novel study of the human thrombocytosis disease through a multi-layered genetic, microRNA and proteomic platelet modeling and analysis in a systems biology scheme. This includes (1) the extraction of distinctive messenger RNA and microRNA expression profiles in human platelets for two subtypes of thrombocytosis patients versus the normal control group, (2) the derivation of a classification model that differentiates between subtypes of thrombocytosis as well as between general diseased and normal subjects using classical and modern discriminant analysis methods, (3) the profiling of platelet microRNAs in thrombocytosis and controls, (4) a microRNA-mRNA correlational analysis to identify a joint genetic and microRNA biological regulatory network in thrombocytotic platelets, and (5) The final validation of identified joint genetic and microRNA platelet regulatory pathways using preliminary proteomics data. This system biological study of the thrombocytosis sets stage for further exploration of the disease mechanism and a more comprehensive recognition of the underlying etiologies. In summary, this dissertation features the discoveries of cellular regulatory networks underlying human thrombocytosis based on the analysis of the joint platelet genetic, microRNA and proteomic data under the system biology scheme. Further expansion is expected to advance our understanding of the platelet maturation pathway under the pathological environment of human thrombocytosis.
机译:人类血小板增多症是一种骨髓增生性疾病(MPD),其特征是遗传和表观遗传因素发生复杂的变化。因此,转录组的失调,干扰组的畸变,蛋白质水平的不规则性和破坏的细胞途径会渗透到病理细胞环境中。在本文中,我们通过系统生物学方案中的多层遗传,microRNA和蛋白质组学血小板建模和分析,对人类血小板增多症进行了新颖的研究。这包括(1)提取两种血小板减少症患者与正常对照组的人血小板中独特的信使RNA和microRNA表达谱,(2)推导区分血小板减少症的亚型以及一般性血小板减少症的分类模型使用经典和现代判别分析方法对患病和正常受试者进行分析;(3)对血小板增多症和对照中的血小板微RNA进行分析;(4)进行微RNA-mRNA相关性分析,以鉴定血小板减少性血小板中的联合遗传和微RNA生物学调控网络;以及( 5)使用初步的蛋白质组学数据对已鉴定的联合遗传和microRNA血小板调节途径进行最终验证。对血小板增多症的这一系统生物学研究为进一步探索疾病机理和更全面地认识潜在病因奠定了基础。综上所述,本文基于系统生物学方案下联合血小板遗传学,microRNA和蛋白质组学数据的分析,揭示了人类血小板增多的细胞调控网络的发现。在人类血小板增多症的病理环境下,预期进一步扩展将促进我们对血小板成熟途径的理解。

著录项

  • 作者

    Xu, Xiao.;

  • 作者单位

    State University of New York at Stony Brook.;

  • 授予单位 State University of New York at Stony Brook.;
  • 学科 Biology Biostatistics.;Health Sciences Medicine and Surgery.;Engineering Biomedical.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 112 p.
  • 总页数 112
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号